Clinical Trials
All Clinical Trials - Page 38 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03353350Phase 3Completed
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Efpeglenatide
- NCT02972060Phase 2Active Not Recruiting
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
Gonadorelin
- NCT03421639Phase 4Unknown
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
Gonadorelin
- NCT03291821N/ACompleted
DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore
Gonadorelin
- NCT03400722Phase 4Unknown
Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response
Gonadorelin
- NCT04839237Phase 2Withdrawn
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
Liraglutide
- NCT03239119Phase 3Unknown
The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
Exenatide
- NCT03523273Phase 2Completed
Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
Liraglutide
- NCT03036800Phase 4Completed
Saxenda in Obesity Services (STRIVE Study)
Liraglutide
- NCT03352869Phase 4Completed
Research of Exenatide for Overweight/Obese PCOS Patients With IGR
Exenatide
- NCT03332797Phase 1Active Not Recruiting
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
Gonadorelin
- NCT03287076Phase 2Unknown
Trial of EXenatide in Acute Ischaemic Stroke
Exenatide
- NCT02956447Phase 2Completed
Administration of Kisspeptin in Patients With Hyperprolactinemia
Kisspeptin
- NCT03444142Phase 4Unknown
Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
Dulaglutide
- NCT03322631Phase 1Completed
A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
Tirzepatide
- NCT05304169Phase 4Completed
Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.
Gonadorelin
- NCT03878706N/ARecruiting
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
MOTS-c
- NCT03315780Phase 4Completed
A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
Dulaglutide
- NCT03325387Phase 1Completed
A Study of Multiple Doses of LY3305677 in Healthy Participants
Mazdutide
- NCT03449654Phase 4Completed
Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
Liraglutide
- NCT03448744Phase 4Unknown
Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients
Thymosin-Alpha-1
- NCT03142035N/AUnknown
Dienogest Versus GnRH-a Pre-treatment in Women With Endometriosis Undergoing IVF
Gonadorelin
- NCT03371862Phase 2Withdrawn
Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
Liraglutide
- NCT03311724Phase 2Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Tirzepatide
- NCT03323749Phase 3Terminated
A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension
Elamipretide
- NCT03471728N/ACompleted
Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)
Linaclotide
- NCT03389412Phase 4Completed
The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.
Desmopressin
- NCT03292185Phase 1Completed
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
Liraglutide
- NCT03279731Phase 3Terminated
Binge Eating Liraglutide Intervention
Liraglutide
- NCT03273712Phase 2Completed
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
Octreotide
- NCT03534661Phase 2/Phase 3Completed
L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
Teduglutide
- NCT03936049N/ACompleted
Replication of the LEADER Diabetes Trial in Healthcare Claims
Liraglutide
- NCT03288740Phase 1Completed
A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
Semaglutide
- NCT03289741Phase 4Completed
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
Octreotide
- NCT03361098Phase 4Completed
DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
Exenatide
- NCT03160261Phase 4Completed
Effect of Exenatide on Cortisol Secretion
Exenatide
- NCT03252353Phase 3Unknown
Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly
Octreotide
- NCT03268811Phase 3Completed
A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302
Teduglutide
- NCT03070704N/AWithdrawn
Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
Liraglutide
- NCT03520062N/ACompleted
The Effect of Liraglutide on Pancreatic Hormones and Its Size
Liraglutide
- NCT03182426Phase 1/Phase 2Completed
Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
Liraglutide
- NCT03262610Phase 2Completed
Setmelanotide in a Single Patient With Partial Lipodystrophy
Setmelanotide
- NCT02932501N/AUnknown
Medication-related Osteonecrosis of the Jaw (MRONJ) Registry
Teriparatide
- NCT03232112Phase 2Completed
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
Exenatide
- NCT03235050Phase 2Completed
A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
Liraglutide
- NCT03804411Phase 4Unknown
Prognostic Predictors of Response to Hypoglycemic Therapy
Liraglutide
- NCT07840313N/ACompleted
Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal Impairment
Desmopressin
- NCT03263299Phase 4Unknown
Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol
Gonadorelin
- NCT02859064Phase 2Terminated
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
Lanreotide
- NCT03201419Phase 2Completed
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
Desmopressin